Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron in Alcohol Use Disorder
NCT02354703Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Aug 2015
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ondansetron in alcohol use disorder (AUD) (4 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Drinks Per Drinking Day at 16 weeks. Started Aug 2015; status: completed.
02
Drugs
ondansetron
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02354703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02354703.